Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/29531Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Thomas, T. | - |
| dc.contributor.author | Casado, E. | - |
| dc.contributor.author | GEUSENS, Piet | - |
| dc.contributor.author | Lems, W. | - |
| dc.contributor.author | Hofbauer, C. | - |
| dc.date.accessioned | 2019-09-17T12:11:20Z | - |
| dc.date.available | 2019-09-17T12:11:20Z | - |
| dc.date.issued | 2019 | - |
| dc.identifier.citation | OSTEOPOROSIS INTERNATIONAL, 30(S2), p. S632-S633 | - |
| dc.identifier.issn | 0937-941X | - |
| dc.identifier.uri | http://hdl.handle.net/1942/29531 | - |
| dc.description.sponsorship | The study was designed and overseen by Jen Timoshanko (UCB Pharma) and Daniella Taylor (Ogilvy Healthworld) with Thierry Thomas and Lorenz Hofbauer as the chairs of the panel. The study was funded by UCB Pharma and Amgen. Editorial services for the abstract were provided by Costello Medical. The authorship would like to thank those that participated in the expert panel. | - |
| dc.language.iso | en | - |
| dc.publisher | SPRINGER LONDON LTD | - |
| dc.title | Does a treat-to-target strategy apply in the management of patients with fragilityfractures? A European overview | - |
| dc.type | Journal Contribution | - |
| local.bibliographicCitation.conferencedate | APR 04-07, 2019 | - |
| local.bibliographicCitation.conferencename | World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO) | - |
| local.bibliographicCitation.conferenceplace | Paris, FRANCE | - |
| dc.identifier.epage | S633 | - |
| dc.identifier.issue | S2 | - |
| dc.identifier.spage | S632 | - |
| dc.identifier.volume | 30 | - |
| local.format.pages | 2 | - |
| local.bibliographicCitation.jcat | M | - |
| dc.description.notes | [Thomas, T.] Univ Lyon, CHU St Etienne, INSERM, U1059, St Etienne, France. [Casado, E.] Univ Hosp Parc Tauli, Barcelona, Spain. [Geusens, P.] Maastricht Univ, Maastricht, Netherlands. [Geusens, P.] Hasselt Univ, Hasselt, Belgium. [Lems, W.] Univ Amsterdam, Med Ctr, VUmc, Amsterdam, Netherlands. [Hofbauer, C.] Tech Univ Dresden, Dresden, Germany. | - |
| local.publisher.place | LONDON | - |
| local.type.refereed | Refereed | - |
| local.type.specified | Meeting Abstract | - |
| dc.identifier.isi | 000475685503182 | - |
| item.fulltext | No Fulltext | - |
| item.contributor | Thomas, T. | - |
| item.contributor | Casado, E. | - |
| item.contributor | GEUSENS, Piet | - |
| item.contributor | Lems, W. | - |
| item.contributor | Hofbauer, C. | - |
| item.fullcitation | Thomas, T.; Casado, E.; GEUSENS, Piet; Lems, W. & Hofbauer, C. (2019) Does a treat-to-target strategy apply in the management of patients with fragilityfractures? A European overview. In: OSTEOPOROSIS INTERNATIONAL, 30(S2), p. S632-S633. | - |
| item.accessRights | Closed Access | - |
| crisitem.journal.issn | 0937-941X | - |
| crisitem.journal.eissn | 1433-2965 | - |
| Appears in Collections: | Research publications | |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.